Loading...

EKSO EKSO BIONICS HOLDINGS INC Capital Structure Changes 8-K Filing

KS B

KS

EKSO BIONICS HOLDINGS INC

(EKSO)

2023 8-K

Show Summary

Show Summary

Reverse Stock Split

Financial Statements

Warrant Agreement

Financial Results

Q4 2024 Results

Nasdaq Compliance Notice

Financial Results

Public Offering

Financial Results

Amendment to Initial 8-K

Annual Meeting of Stockholders

Financial Results

Financial Results Announcement

Securities Purchase Agreement

Financial Statements and Ex...

Financial Results Announcement

Compliance with Minimum Bid...

Agreement and Non-complianc...

Loan Agreement Amendment

Financial Results

Amendment to At the Market ...

Financial Results

Departure of Director, CEO ...

Financial Results

External Links:

Ekso Bionics Holdings, Inc. regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

AI Assistant

EKSO BIONICS HOLDINGS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.